|
| 36334654 | Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD. | Transplant Cell Ther | 2023 |
| 37467030 | Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence. | Blood Adv | 2023 |
| 36243319 | Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge. | Transplant Cell Ther | 2023 |
| 34845367 | Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study. | Bone Marrow Transplant | 2022 |
| 35860252 | Negative Regulation of Zap70 by Lck Forms the Mechanistic Basis of Differential Expression in CD4 and CD8 T Cells. | Front Immunol | 2022 |
| 36111255 | Two types of human TCR differentially regulate reactivity to self and non-self antigens. | iScience | 2022 |
| 36005208 | Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. | Curr Oncol | 2022 |
| 34954149 | Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective. | Transplant Cell Ther | 2022 |
| 33022376 | UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections. | Transplant Cell Ther | 2021 |
| 30833742 | The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation. | Bone Marrow Transplant | 2020 |
| 31704264 | Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study. | Lancet Haematol | 2020 |
| 32047237 | ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. | Leukemia | 2020 |
| 33036618 | Closing the system: production of viral antigen-presenting dendritic cells eliciting specific CD8<sup>+</sup> T cell activation in fluorinated ethylene propylene cell culture bags. | J Transl Med | 2020 |
| 32974613 | Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on <i>MIR300</i> Antiproliferative and PP2A-Activating Functions. | Blood Cancer Discov | 2020 |
| 32981146 | Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. | Clin Transplant | 2020 |
| 32553596 | Analysis of the COMPARE-AMI trial: First report of long-term safety of CD133+ cells. | Int J Cardiol | 2020 |
| 31521818 | Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma. | Biol Blood Marrow Transplant | 2020 |
| 31537691 | Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT. | Haematologica | 2020 |
| 30654975 | Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease. | Leuk Res | 2019 |
| 30244108 | Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity. | Biol Blood Marrow Transplant | 2019 |
| 30232413 | Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. | Bone Marrow Transplant | 2019 |
| 31604534 | Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment. | Semin Immunol | 2019 |
| 31036767 | Critical Role for TCR Signal Strength and MHC Specificity in ThPOK-Induced CD4 Helper Lineage Choice. | J Immunol | 2019 |
| 31135970 | Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis. | Br J Haematol | 2019 |
| 29339270 | Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium (HAPLO2016), San Diego, California, December 1, 2016. | Biol Blood Marrow Transplant | 2018 |
| 29617431 | Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells. | PLoS One | 2018 |
| 29335625 | The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. | Bone Marrow Transplant | 2018 |
| 28183746 | Major vs minor histocompatibility antigens. | Blood | 2017 |
| 26691426 | Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation. | Bone Marrow Transplant | 2016 |
| 26340545 | Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy. | Coron Artery Dis | 2016 |
| 27665225 | The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133<sup>+</sup> stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy. | J Thorac Cardiovasc Surg | 2016 |
| 26806585 | Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. | Biol Blood Marrow Transplant | 2016 |
| 26857467 | Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers. | Leukemia | 2016 |
| 25661862 | Early exposure to interleukin-21 limits rapidly generated anti-Epstein-Barr virus T-cell line differentiation. | Cytotherapy | 2015 |
| 24485220 | Policy recommendations for addressing privacy challenges associated with cell-based research and interventions. | BMC Med Ethics | 2014 |
| 25457957 | CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada. | Stem Cells Dev | 2014 |
| 25237102 | Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. | Science | 2014 |
| 25228333 | Harnessing the power of alloreactivity without triggering graft-versus-host disease: how non-engrafting alloreactive cellular therapy might change the landscape of acute myeloid leukemia treatment. | Blood Rev | 2014 |
| 24793546 | Medium conditioned with mesenchymal stromal cell-derived osteoblasts improves the expansion and engraftment properties of cord blood progenitors. | Exp Hematol | 2014 |
| 24503485 | Inability of HOXB4 to enhance self-renewal of malignant B cells: favorable profile for the expansion of autologous hematopoietic stem cells. | Exp Hematol | 2014 |
| 23253556 | Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma. | Biol Blood Marrow Transplant | 2013 |
| 23970380 | Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias. | Blood | 2013 |
| 23999433 | PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. | J Clin Invest | 2013 |
| 23670294 | Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. | Leukemia | 2013 |
| 23725864 | Reply to letter from Kopjar et al.-the IMPACT-CABG Pilot Trial. | Can J Cardiol | 2013 |
| 23495088 | Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment. | Stem Cells | 2013 |
| 23265095 | Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial. | Can J Cardiol | 2013 |
| 21399672 | Cardiac tamponade potentially related to sirolimus following cord blood transplantation. | Bone Marrow Transplant | 2012 |
| 23206844 | Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. | Semin Oncol | 2012 |
| 23024264 | Preconditioning of stem cells by oxytocin to improve their therapeutic potential. | Endocrinology | 2012 |